|
Market Closed -
Nasdaq
01:30:00 27/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 76.99 USD | +0.03% |
|
-.--% | +182.32% |
| 31/08 | Forte Biosciences, Inc.(NasdaqGM:FBRX) dropped from Russell 3000E Growth Index | CI |
| 31/08 | Forte Biosciences, Inc.(NasdaqGM:FBRX) dropped from Russell Microcap Growth Index | CI |
Company Valuation: Forte Biosciences
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 467.2 | 31.57 | 21 | 29.86 | 145.2 | 486.3 |
| Change | - | -93.24% | -33.49% | 42.17% | 386.3% | 234.91% |
| Enterprise Value (EV) 1 | 408.4 | -10.47 | -20.1 | -7.268 | 86.83 | 409.3 |
| Change | - | -102.56% | -91.99% | 63.84% | 1,294.58% | 371.4% |
| P/E | -5.76x | -1.38x | -1.25x | -0.82x | -1.87x | -5.79x |
| PBR | 7.92x | 0.76x | 0.54x | 0.85x | 2.77x | 7.97x |
| PEG | - | 0x | 0x | -0x | 0x | 0.1x |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -28.8x | 0.49x | 1.45x | 0.22x | -2.37x | -5.8x |
| EV / EBIT | -28.7x | 0.49x | 1.45x | 0.22x | -2.37x | -5.79x |
| EV / FCF | -50.4x | 1.16x | 6.31x | 0.42x | -5.38x | -15.2x |
| FCF Yield | -1.98% | 86.2% | 15.8% | 239% | -18.6% | -6.58% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -157.9 | -38.85 | -20 | -24.92 | -12.17 | -4.714 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | - | - |
| EBITDA 1 | -14.17 | -21.45 | -13.86 | -32.48 | -36.56 | -70.59 |
| EBIT 1 | -14.22 | -21.49 | -13.9 | -32.49 | -36.6 | -70.66 |
| Net income 1 | -46.49 | -21.71 | -13.88 | -31.48 | -35.48 | -69.38 |
| Net Debt 1 | -58.76 | -42.04 | -41.1 | -37.12 | -58.36 | -76.96 |
| Reference price 2 | 910.25 | 53.50 | 25.00 | 20.54 | 22.71 | 27.27 |
| Nbr of stocks (in thousands) | 513 | 590 | 840 | 1,453 | 6,393 | 17,831 |
| Announcement Date | 16/03/21 | 31/03/22 | 31/03/23 | 18/03/24 | 28/03/25 | 31/03/26 |
1USD in Million2USD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FBRX Stock
- Valuation Forte Biosciences
Select your edition
All financial news and data tailored to specific country editions
